Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10795 publications
Effects of Dapagliflozin on Left Atrial Ejection Force in Heart Failure with Preserved Ejection Fraction: DAPA-Left Atrial Ejection Force Trial.
Journal: Anatolian journal of cardiology
Published: October 20, 2025
Updates on the Endothelial Glycocalyx in Heart Failure with Preserved Ejection Fraction.
Journal: American journal of physiology. Heart and circulatory physiology
Published: October 10, 2025
Letter to the editor: Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction.
Journal: American heart journal
Published: October 09, 2025
Response to letter by Naeem regarding article, "Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction".
Journal: American heart journal
Published: October 09, 2025
Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: October 06, 2025
Cardiovascular MRI Feature-Tracking Strain Rate for Assessment of Diastolic Function.
Journal: Radiology. Cardiothoracic imaging
Published: October 02, 2025
Beta-Blocker Use in Post-Myocardial Infarction Patients With Preserved Ejection Fraction: A Review.
Journal: Cardiology in review
Published: September 30, 2025
Nothing Is Wrong With My Heart: Patient-Reported Understanding of Heart Failure With Preserved Ejection Fraction.
Journal: Journal of the American Heart Association
Published: September 30, 2025
Mechanisms of exercise limitation in heart failure with preserved ejection fraction and obesity: A case of engine-chassis mismatch.
Journal: American journal of physiology. Heart and circulatory physiology
Published: September 30, 2025
Microglial metabolic reprogramming drives cognitive decline in heart failure with preserved ejection fraction.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
Empagliflozin Attenuates Diabetic Cardiomyopathy via Inhibiting Cardiomyocyte Ferroptosis Through the USP7/NRF2 Signaling Pathway.
Journal: Antioxidants & redox signaling
Published: September 26, 2025
Last Updated: 10/31/2025